Ricevi le ultime notizie sulle azioni Zentalis Pharma con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ZNTL

Ultime notizie per

ZENTALIS PHARMACEUTICALS INC

Zentalis Pharma

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharmaceuticals Inc

Health Care

Press Releases

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

Markets

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Earnings

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Progress

News

Management

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

General

ZNTL

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Anixa Biosciences

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Clene

Climb Bio

Coya Therapeutics

EXoZymes

InflaRx

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Opus Genetics

Macrogenics

Metagenomi

Quince Therapeutics

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Spero Therapeutics

Surrozen

Shattuck Labs

TScan Therapeutics

Instil Bio

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Comments

Zentalis Pharma Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO